XNCR

33.2602.21%
AB

Alan Bruce Montgomery

lead Independent Director

Dr. Alan Bruce Montgomery, M.D., serves as Chair of Clinical Advisory Board at SoftOx Solutions AS since September 2026. He has been Chief Executive Officer and a Member of The Board of Directors of Avalyn Pharma (formerly Genoa Pharmaceuticals) which he joined in 2017. From 2011 to 2016, Dr. Montgomery served as Chief Executive Officer and a Member of The Board of Directors at Cardeas Pharma Corp. that he founded in 2010. He serves as Lead Independent Director at Xencor, Inc. Dr. Montgomery serves Chief Executive Officer at Cardiac Science Corp and at Criticare Systems. He served as an Executive Director of Cardeas Pharma Corp. Dr. Montgomery is a Prominent Biotech Entrepreneur with an extensive background in product development and clinical studies. Dr. Montgomery hasmany years of drug development, operations and financing experience. He has extensive pharmaceutical research, development and patent experience. He was Senior Vice President and Head of Respiratory Therapeutics at Gilead Sciences Inc. since August 2006 until May 2011. He has skills in fundraising. From 1989 to November 1993, he served as an Associate Director of Clinical Research at Genentech, Inc., where Dr. Montgomery was involved in the clinical development of Pulmozyme. Before joining Cardeas Pharma Corporation in 2010, Dr. Montgomery founded Corus Pharma, Inc. in January 2001 and served as its President, Chief Executive Officer and Treasurer from 2001 to 2006. While at Gilead, Dr. Montgomery successfully led the development of Cayston (aztreonam) as a treatment for cystic fibrosis patients. Previously, Dr. Montgomery served as an Executive Vice President of Research and Development at Pathogenesis Corporation from January 1998 to 2000. He joined Pathogenesis in 1993 and served as its Vice President of Medical and Regulatory Affairs from December 1993 to July 1995 and as its Senior Vice President of Research and Development from July 1995 to January 1998. He served as Director of the Medical Intensive Care Unit, Pulmonary Disease Section, Department of Medicine and State University of New York. Dr. Montgomery has been a Director of Geospiza, Inc. since October 2010. Dr. Montgomery serves as a Director at M3 biopharma. Dr. Montgomery has been a Director of Xencor, Inc. since March 18, 2015 and served as Director at Alder Biopharmaceuticals Inc. since October 2010 until October 22, 2019. He served as an Independent Director at CytoDyn Inc. since September 27, 2013 until July 11, 2018. He served as a Trustee of Seattle Biomedical Research Institute. He served as a Director of Vascular Reconditioning Inc., Corus Pharma, Inc. and Light Sciences Corporation. Dr. Montgomery served as a Director of Army Science Board. He was a Director of Vizx Labs, LLC. Dr. Montgomery served as a Director for ZymoGenetics Inc. from March 2010 to October 8, 2010. He is a Director of American Lung Association and a Board Member of Alder Biotherapeutics. Dr. Montgomery is a Trustee of the Washington State Life Sciences Fund. He was a Board Member of Pacific Science Center. He served on the board of the Life Science Discovery Fund, the Army Science Board and the Pacific Science Center. He was a Trustee of the Washington State Biotechnology BioMedical Association. Dr. Montgomery was an Assistant Professor of Medicine at State University of New York. His academic career included Assistant Professorships at both UCSF and SUNY Stony Brook, where he directed the ICU. He is a Co-inventor of two patents related to aerosolized pentamidine and has led six new drugs through FDA approval. Dr. Montgomery received the Patriotic Civilian service Award from the Secretary of the Army in 1997. He is a Serial Entrepreneur. Dr. Montgomery is a board-certified Internist and Pulmonologist and holds an MD and a B.S. degree in Chemistry from the University of Washington. He completed his Residency in Internal Medicine at the University of Washington and fellowships at the University of Washington and the University of California, San Francisco.

Positions